. 2021 Mar 15;5(6):1081–1094. doi: 10.1002/hep4.1694
© 2021 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of the American Association for the Study of Liver Diseases.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
FIG. 4.
Rates of serious opioid‐related adverse events by hepatic decompensation status.